10:25am ET
Health and Healthcare
How Amgen Can Disrupt the Market for Cholesterol Drugs
Amgen has the potential to disrupt the market for cholesterol drugs with the newest addition to its drug portfolio.
Chris Lange
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 10:48pm ET
AMGN Coverage
Page 28 Chris Lange 8:55am ET
Health and Healthcare
Short Sellers Become More Focused in Major Biotechs
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
8:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
2:20pm ET
Health and Healthcare
5 Big FDA Decisions Expected in August
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of August and added some color.
11:25am ET
Health and Healthcare
Independent Research Firm Sees Higher Upside in Amgen
According to Argus, second-quarter earnings, along with a strong pipeline and general outlook, have positioned Amgen to take the market by storm.
Chris Lange 4:26pm ET
Health and Healthcare
Amgen Earnings Point to New 52-Week High
ThinkstockAmgen Corp. (NASDAQ: AMGN) reported fiscal second quarter 2015 earnings Thursday afternoon after equity markets had closed. The biotech firm posted adjusted earnings per share (EPS) of $2.57 on revenues of $5.37…
Paul Ausick 11:23am ET
Health and Healthcare
What to Expect from Amgen Earnings
ThinkstockAmgen Inc. (NASDAQ: AMGN) is scheduled to report its earnings after the markets close on Thursday. There are consensus estimates from Thomson Reuters that call for $2.43 in earnings per share (EPS)…
Chris Lange 7:57am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…
10:21am ET
Health and Healthcare
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK)…
8:50am ET
Health and Healthcare
4 Large Cap Biotech Stocks to Buy Before Earnings
A new research report from Cowen focuses on the top biotech stocks to buy before second-quarter earnings are reported.
7:55am ET
Health and Healthcare
Short Sellers Back Off Big Biotech
24/7 Wall St. has reviewed the short interest in top biotech companies, without focusing on speculative companies.
10:15am ET
Investing
4 Defensive Stocks to Buy Now for Continued Market Volatility
None of these stocks are on the momentum traders' radar, and that is exactly what prudent growth investors need now.
7:35am ET
Health and Healthcare
5 Big Upcoming FDA Decisions Expected in July
24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of July and added some color.
7:50am ET
Health and Healthcare
Short Sellers Get More Selective on Big Biotech
The short interest data are out for the June 15 settlement date, and overall, short interest in the selected biotech stocks was mixed.
7:55am ET
Health and Healthcare
Short Sellers Lose Some Conviction Against Big Biotech
The May 29 short interest data have been compared with the previous figures, and for most of the selected biotech stocks, short interest has decreased.